Marginum
PrivateLast Round
VC Round
Aug 22, 2025
Total Funding Raised
$1.82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Marginum operates in Healthcare & Life Sciences and is based in Finland. Its latest recorded funding round was a VC Round in August 2025.
Marginum is a medical technology company that develops fluorescence-based tissue detection systems designed to help medical professionals treat cancer in patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marginum Comparables
Compare Marginum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beams | 85% | |
| Celeos SAS | 83% | |
| OnLume Surgical | 79% |
For institutional investors. Book with your work email.
Marginum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 22, 2025 | ||||
| Seed | Nov 10, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Marginum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nostetta Ventures | VC Round, Seed |
| Lynx Financial | VC Round |
| Business Finland | VC Round, Seed |
| Redstone VC | VC Round, Seed |
| Almaral | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 143% MoM, reaching 2.2K.
- Jun 24, 2026
Monthly visitors grew 100% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardAug 27, 2026
Marginum Oy receives the 2026 Export2X Internationalisation Award from the Kuopio Region Chamber of Commerce in Finland on Aug 27th '26 for its rapid international growth and successful commercialisation of research-based medical technology.
- partners_withAug 11, 2026
On Aug 11th '26 in Finland, Marginum Oy partners with ABS Med, Inc. under a U.S. distribution agreement to support the planned commercialization and distribution of the HIVEN(R) device across nine U.S. states, subject to FDA authorization.
For institutional investors. Book with your work email.
Marginum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Marginum's valuation, stock price, and market status.
Is Marginum a public or private company?
Marginum is a private company.
What is the current stock price of Marginum?
Marginum is a private company, so its shares have no public market price. Caplight tracks Marginum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Marginum worth (valuation)?
Valuation information for Marginum is not publicly available.
Can I buy Marginum stock?
Marginum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Marginum's last funding round?
Marginum's most recent funding round was VC Round on August 22, 2025.
Who are the main investors in Marginum?
Key investors in Marginum include Nostetta Ventures, Redstone VC, Almaral.
Will Marginum IPO soon?
No public IPO plans have been announced for Marginum.
How can I track Marginum secondary market activity?
Caplight tracks bids, offers, and trades in Marginum's shares on secondary markets.